Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1591 (LINC01591) is a member of the long non-coding RNA (lncRNA) family, specifically an intergenic lncRNA, meaning it is transcribed from a genomic region that does not overlap with known protein-coding genes[1][3]. LINC01591 does not encode a protein, and as of current scientific knowledge, there are no well-established biological functions, roles in specific diseases, or clinical utility documented in the major gene and functional annotation resources[1][3]. It is recognized as a non-coding transcript, and there is little to no evidence in the literature supporting its role as a therapeutic target, biomarker, or regulator in canonical signaling or disease pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1591 (LINC01591).